OmniAb (OABI) EBITDA (2021 - 2026)
OmniAb's (OABI) quarterly EBITDA came in at -$7.8 million in Q1 2026, up 58.45% year-on-year from -$4.9 million in Q1 2025, and up 50.34% on a QoQ basis from -$15.8 million in Q4 2025.
OmniAb (OABI) EBITDA (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of EBITDA data on file, last reported at -$7.8 million in Q1 2026.
- On a quarterly basis, EBITDA rose 58.45% year-over-year to -$7.8 million in Q1 2026; TTM through Mar 2026 was -$58.0 million, a 18.14% increase from a year earlier, with the FY2025 full-year figure at -$69.0 million, up 7.43% from the prior year.
- EBITDA for Q1 2026 stood at -$7.8 million, up from -$15.8 million in the prior quarter.
- Over the last five years, EBITDA for OABI reached as high as $9.0 million in Q4 2022 and fell as low as -$22.6 million in Q1 2024.
- Historically, EBITDA has averaged -$14.6 million across 5 years, with a median of -$16.2 million in 2025.
- On a YoY basis, EBITDA climbed as much as 125.54% in 2022 and fell as far as 575002.97% in 2022.
- Year by year, EBITDA stood at $9.0 million in 2022, then sank by 334.32% to -$21.2 million in 2023, then rose by 25.12% to -$15.9 million in 2024, then increased by 0.72% to -$15.8 million in 2025, then jumped by 50.34% to -$7.8 million in 2026.
- Per Business Quant data, the three most recent EBITDA figures were -$7.8 million in Q1 2026, -$15.8 million in Q4 2025, and -$18.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 394.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -445.22 Mn |
| 10 | OmniAb | 263.54 Mn | 214.47 Mn | 14.41 Mn | -7.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.83 Mn |
| Dec 31, 2025 | -15.77 Mn |
| Sep 30, 2025 | -18.14 Mn |
| Jun 30, 2025 | -16.22 Mn |
| Mar 31, 2025 | -18.84 Mn |
| Dec 31, 2024 | -15.88 Mn |
| Sep 30, 2024 | -19.76 Mn |
| Jun 30, 2024 | -16.31 Mn |
| Mar 31, 2024 | -22.55 Mn |
| Dec 31, 2023 | -21.21 Mn |
| Sep 30, 2023 | -20.32 Mn |
| Jun 30, 2023 | -19.45 Mn |
| Mar 31, 2023 | -8.45 Mn |
| Dec 31, 2022 | 9.05 Mn |
| Sep 30, 2022 | -14.91 Mn |
| Jun 30, 2022 | -12.57 Mn |
| Mar 31, 2022 | -8.22 Mn |
| Dec 31, 2021 | -35.43 Mn |
| Sep 30, 2021 | -170,579.00 |
| Jun 30, 2021 | -2,185.00 |